These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35806369)

  • 1. Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2.
    Zhang C; Meng X; Zhao H
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of virus-mediated cell fusion rate of SARS-CoV-2.
    Amidei A; Dobrovolny HM
    Virology; 2022 Oct; 575():91-100. PubMed ID: 36088794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
    Jocher G; Grass V; Tschirner SK; Riepler L; Breimann S; Kaya T; Oelsner M; Hamad MS; Hofmann LI; Blobel CP; Schmidt-Weber CB; Gokce O; Jakwerth CA; Trimpert J; Kimpel J; Pichlmair A; Lichtenthaler SF
    EMBO Rep; 2022 Jun; 23(6):e54305. PubMed ID: 35527514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike-mediated cell-to-cell fusion.
    Zhang YY; Liang R; Wang SJ; Ye ZW; Wang TY; Chen M; Liu J; Na L; Yang YL; Yang YB; Yuan S; Yin X; Cai XH; Tang YD
    J Biol Chem; 2022 Nov; 298(11):102511. PubMed ID: 36259516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic activation of SARS-CoV-2 spike protein.
    Takeda M
    Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spike protein mediated membrane fusion during SARS-CoV-2 infection.
    Li X; Yuan H; Li X; Wang H
    J Med Virol; 2023 Jan; 95(1):e28212. PubMed ID: 36224449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
    Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
    mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
    Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
    Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis for the Understanding of Entry Inhibitors against SARS Viruses.
    Kushwaha PK; Kumari N; Nayak S; Kishor K; Sharon A
    Curr Med Chem; 2022; 29(4):666-681. PubMed ID: 33992054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 Interactions.
    Lin H; Cherukupalli S; Feng D; Gao S; Kang D; Zhan P; Liu X
    Curr Med Chem; 2022; 29(4):682-699. PubMed ID: 33881969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms for understanding the association between TMPRSS2 and beta coronaviruses SARS-CoV-2, SARS-CoV and MERS-CoV infection: scoping review.
    Chaves-Medina MJ; Gómez-Ospina JC; García-Perdomo HA
    Arch Microbiol; 2021 Dec; 204(1):77. PubMed ID: 34953136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody.
    Basile A; Zannella C; De Marco M; Sanna G; Franci G; Galdiero M; Manzin A; De Laurenzi V; Chetta M; Rosati A; Turco MC; Marzullo L
    Antiviral Res; 2023 Mar; 211():105546. PubMed ID: 36669656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.